Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...

The University of St. Thomas started a program to serve those students, and now, five years later, university officials say, ...

NEW YORK, NY, UNITED STATES, January 8, 2026 /EINPresswire.com/ -- Blending Medical Expertise, Faith, and Personal ...

U.S. Food and Drug Administration (FDA) allows advancement of RAP-219 into registrational trials for focal onset seizures ...

A year-long project to increase the size of the neurological intensive care unit at Mercy Health in Youngstown is now ...

A Billings audiologist explains why professional hearing tests and properly fitted hearing aids offer safer, clearer, ...

Mr. Olympia Danny Hester joins NF1 to advance science-backed training, recovery, and gut health through RESET and the NF1 performance platform. Training doesn’t stop working—you just need the right ...

A New York law grants patients the right to request aid in dying. But do the clinicians who guide them through that decision ...

Breakthrough therapy designation granted as Company advances the PIONEER registrational program in optic neuropathies to create a potential market of $7B+ in the U.S. aloneMultiple milestones anticipa ...

The neurointensive care unit at St. Elizabeth’s Youngstown Hospital expanded from four beds to 16 beds each in private rooms.

Positive interim efficacy data in 2025 underscore potential of ETX101 as a one-time, disease-modifying medicine for Dravet syndrome –– Internal GMP manufacturing capable of supporting pivotal trial ...

Partnership addresses the unmet need for remyelination therapies for multiple sclerosis and other demyelinating conditions by ...